首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A
Authors:R. F. GAGEL  G. J. COTE  M. J. G. MARTINS BUGALHO  A. E. BOYD III  T. CUMMINGS  H. GOEPFERT  D. B. EVANS  A. CANGIR  S. KHORANA  P. N. SCHULTZ
Abstract:Abstract. One hundred and ninety-seven members of 28 kindreds with multiple endocrine neoplasia type 2A (MEN 2A) were screened for RET proto-oncogene exon 10 and 11 mutations. Seventy-one known affected individuals had mutations of codons 609, 618, 620 or 634, whereas 53 unaffected individuals had no abnormalities. Nineteen out of 54 individuals of unknown status, mostly children, had RET mutations. Four of these children had thyroidectomy based on this analysis and were found to have C-cell abnormalities. We identified one false negative mutation analysis because of a codon 691 polymorphism. We conclude that RET mutational analysis is a cost-effective and accurate method for determination of gene carrier status in MEN 2A.
Keywords:genetic screening  Hyperparathyroidism  medullary thyroid carcinoma  multiple endocrine neoplasia type 2A  mutation analysis  pheochromocytoma  RET proto-oncogene
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号